Giant Cell Arteritis versus Takayasu Arteritis: An Update. 2020

Pavlos Stamatis
Department of Clinical Sciences, Rheumatology, Lund University, Sweden.

Giant cell arteritis (GCA) and Takayasu Arteritis (TAK) are two systemic granulomatous vasculitides affecting medium- and large-sized arteries. Similarities in GCA and TAK regarding the clinical presentation, the systemic inflammatory response and the distribution of the arterial lesions, have triggered a debate over the last decade about whether GCA and TAK represent two different diseases, or are age-associated different clinical phenotypes of the same disease. On the other hand, there are differences regarding epidemiology, several clinical features (eg, polymyalgia rheumatica in GCA) and treatment. The aim of this review is to present the latest data regarding this question and to shed some light on the differences and similarities between GCA and TAK regarding epidemiology, genetics, pathogenesis, histopathology, clinical presentation, imaging and treatment. The existing data in literature support the opinion that GCA and TAK are different clinical entities.

UI MeSH Term Description Entries

Related Publications

Pavlos Stamatis
January 2017, Current opinion in rheumatology,
Pavlos Stamatis
August 2018, Turkish journal of medical sciences,
Pavlos Stamatis
January 2007, Current opinion in rheumatology,
Pavlos Stamatis
May 1997, Bailliere's clinical rheumatology,
Pavlos Stamatis
April 2018, European journal of internal medicine,
Pavlos Stamatis
January 2017, Reumatologia clinica,
Pavlos Stamatis
November 2020, Revista medica de Chile,
Pavlos Stamatis
February 2016, International journal of rheumatic diseases,
Pavlos Stamatis
April 2007, Revue medicale suisse,
Copied contents to your clipboard!